Movianto Secures Five-Year NHS England Contract for Vaccine Logistics

NHS England has activated a five-year pharmaceutical logistics contract with Movianto UK, placing the healthcare logistics specialist at the centre of the supply chain supporting England's national vaccination and immunization programmes.

The agreement, awarded following a competitive tender process, covers vaccine storage, inventory management, order fulfilment, sortation and temperature-controlled distribution to more than 11,000 frontline healthcare locations across England. Movianto announced the contract's go-live on 12 August 2026.

Movianto UK, which became part of Yusen Logistics in 2025, will operate as NHS England's strategic logistics partner for the programme. The arrangement is intended to support routine immunization alongside national screening programmes and emergency public health responses, areas where continuity of supply and rapid deployment can be critical.

A central feature of the contract is the use of Movianto's existing healthcare logistics infrastructure rather than the creation of a separate network dedicated exclusively to NHS England.

Its UK network already handles products for pharmaceutical manufacturers, NHS organizations and government departments. Under the new model, capacity across existing warehouses, transport services and inventory systems can be shared between customers while remaining subject to pharmaceutical distribution requirements.

Shared Infrastructure Designed to Reduce Duplication

The shared-user model has both operational and environmental implications.

Instead of maintaining separate warehouses and transport capacity for individual programmes, NHS England can use regulated infrastructure that is already in operation. Movianto says this should improve utilization of existing assets and reduce duplication across warehousing and distribution.

Pharmaceutical suppliers will also be able to move products directly into Movianto's regulated storage network. This is designed to remove some intermediate transfers that might otherwise occur between facilities before products are dispatched to NHS providers.

Fewer transfers can potentially reduce handling requirements, vehicle movements and associated energy consumption. The approach therefore connects healthcare supply chain resilience with NHS England's broader sustainable procurement objectives.

The NHS has committed to reaching net-zero by 2040 for emissions it controls directly, and by 2045 for emissions it can influence, including emissions associated with goods and services purchased from suppliers. Its Net-Zero Supplier Roadmap progressively introduces carbon-related requirements into NHS procurement.

Reducing avoidable transport is particularly relevant for pharmaceutical logistics because temperature-controlled distribution adds energy requirements to conventional freight operations.

Movianto has been upgrading its UK transport fleet with efficiency in mind. In 2025, the company added 100 dual-temperature trucks and vans, which it said improved fuel efficiency by around 20%. The vehicles can transport products across controlled temperature ranges including 2°C to 8°C and 15°C to 25°C, while some equipment can support frozen products at around -20°C.

Its newer vans also use air-curtain systems intended to improve temperature stability while reducing refrigeration use when vehicle doors are opened.

Pharmaceutical Compliance Remains Central

Efficiency improvements cannot come at the expense of pharmaceutical quality requirements.

The NHS contract requires Good Distribution Practice, or GDP-compliant, warehousing and temperature-controlled distribution. UK guidance requires medicinal products to remain within the licensed supply chain and to be stored, transported and handled under conditions appropriate to the product or its marketing authorization.

Maintaining those conditions can be particularly important for vaccines, where deviations from specified storage temperatures may affect product quality or usability.

Movianto's role therefore extends beyond conventional transport. The contract integrates inventory management, warehouse operations, order fulfilment and controlled distribution into a single end-to-end system.

The company says its European network includes 23 logistics centres across 11 countries, with more than 600,000 pallet spaces and over 3,700 employees.

MenB Response Provided an Early Resilience Test

The logistics model was tested shortly before the contract was publicly announced.

In July 2026, Movianto worked with NHS England and other stakeholders to increase operational capacity for an accelerated Meningococcal Group B, or MenB, vaccination programme for young people following reported meningococcal disease cases involving university students in Kent.

The response required vaccines to be distributed rapidly to community pharmacies and other vaccination providers. Movianto said more than 16,000 orders had been processed and delivered under the programme by the time the new contract was announced.

The episode illustrates an important aspect of healthcare logistics resilience: infrastructure must be capable not only of handling predictable routine demand, but also of expanding quickly when public health priorities change.

For NHS England, this means maintaining access to warehouse capacity, inventory visibility and temperature-controlled transport without having to build emergency logistics systems from scratch each time demand rises.

Resilience and Sustainability Increasingly Converge

The Movianto agreement reflects a broader shift in supply chain strategy in which resilience and sustainability are increasingly treated as interconnected rather than competing objectives.

Shared infrastructure can provide spare capacity and operational flexibility while improving the utilization of warehouses and vehicles. Direct supplier integration can shorten distribution pathways, while digital inventory management can help operators position stock more efficiently and respond faster when demand changes.

For healthcare systems, those improvements may simultaneously reduce costs, emissions, product handling, and exposure to disruption.

The contract also demonstrates how environmental criteria are becoming embedded in major public-sector logistics decisions rather than operating as separate sustainability initiatives. NHS England's procurement strategy increasingly requires suppliers to demonstrate progress on carbon reduction alongside traditional considerations such as reliability, compliance and value for money.

With the five-year programme now operational, the effectiveness of the model will depend on its ability to maintain pharmaceutical compliance and routine service levels while retaining sufficient flexibility for emergency responses.

If successful, the arrangement could provide a practical example of how existing logistics infrastructure can be used more intensively to strengthen critical healthcare supply chains while limiting unnecessary transport and additional physical infrastructure.

Source: supplychaindigital.com